Germany metered dose inhaler market is anticipated to grow at a substantial rate of around 4.0% during the forecast period. Germany is one of the key economies of the European region in terms of revenue generation and future opportunities for the metered dose inhaler market. Major factors that augment the growth of the metered dose inhaler market in the country include the significant prevalence of respiratory diseases such as asthma and COPD coupled with increasing geriatric population and growing focus towards the development of therapeutics to treat respiratory diseases.
To Request a Sample of our Report on Germany Metered Dose Inhaler Market: https://www.omrglobal.com/request-sample/germany-metered-dose-inhaler-market
According to the International Monetary Fund, in 2017, the population of the country was about 80 million and the share of the geriatric population is around 21%. Major companies working in the field of respiratory drug and device industry. Ingelheim based Boehringer Ingelheim International GmbH collaborated with Weill Cornell Medicine in February 2017. The collaboration aims to find new treatment approaches for chronic pulmonary diseases. The three-year collaboration aimed to develop novel treatments that could stop and decrease the progression of COPD.
Germany metered dose inhaler market is segmented based on type, application, and end-user. Based on the type, preventive, reliever, and long-acting bronchodilators inhalers are analyzed. The preventive inhaler segment led the global metered dose inhaler market in 2018. Preventive inhalers are most widely used in the treatment of asthma in children and adults. These inhalers do not entail side effects for long-term use, and exceptionally decreases the possibility of an asthma exacerbation. The preventive inhalers further reduce the airways swelling and hence, are recommended for regular use by the physician. Some of the preventive inhalers available in the market include Budesonide and Fluticasone. Moreover, based on the application, the market has been classified into asthma and COPD diseases. In addition, based on the end-user, homecare and hospitals and clinics have been analyzed.
(Get 15% Discount on Buying this Report)
A full Report of Germany Metered Dose Inhaler Market is Available @ https://www.omrglobal.com/industry-reports/germany-metered-dose-inhaler-market
Germany Metered Dose Inhaler Market Segmentation
By Type
- Preventive Dry Powdered Inhaler
- Reliever Dry Powdered Inhaler
- Long Acting Bronchodilators Inhaler
By Application
- Asthma
- Chronic Obstructive Pulmonary Disease (COPD)
By End-User
- Homecare
- Hospitals and Clinics
Company Profiles
- 3M Co.
- Acorda Therapeutics, Inc.
- Adamis Pharmaceuticals Corp
- Adherium Ltd.
- AstraZeneca PLC
- Bespak
- Boehringer Ingelheim International GmbH
- Chiesi Farmaceutici S.P.A.
- GlaxoSmithKline PLC
- H&T Presspart Manufacturing Ltd.
- Koninklijke Philips N.V.
- Novartis AG
- Omron Healthcare Inc.
- ResMed Corp.
- Pulmatrix Inc.
- Savara, Inc.
- Teicos Pharma Ltd.
- Teva Pharmaceuticals Industries Ltd.
- Vitalograph Ltd.
Reasons to buy from us –
- We cover more than 15 major industries, further segmented into more than 90 sectors.
- More than 120 countries are for analysis.
- Over 100+ paid data sources mined for investigation.
- Our expert research analysts answer all your questions before and after purchasing your report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404
